Gilvetmab is the first and only immune checkpoint inhibitor developed for the treatment of mast cell tumors (MCTs) and melanomas in dogs.
LEARN MOREFor the prevention and treatment of Selenium-Tocopherol Deficiency (white muscle disease) syndrome in calves.
LEARN MOREFor the vaccination of healthy chickens 10 to 12 weeks of age against pasteurellosis and turkeys 15 weeks of age against pasteurellosis.
LEARN MORE